Evidence map›Paper›PMID 40342583›Full record

ArticleFrontiers in medicine2025

A scoping review of advancements in machine learning for glaucoma: current trends and future direction.

Jiatong Zhang, Bocheng Tian, Mingke Tian, Xinxin Si, Jiani Li, Ting Fan

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jiatong Zhang *The First Clinical Medical School, China Medical University, Shenyang, China.
Bocheng Tian *The Second Clinical Medical School, China Medical University, Shenyang, China.
Mingke Tian *Emory College of Arts and Sciences, Emory University, Atlanta, GA, United States.
Xinxin SiThe Fourth Clinical Medical School, China Medical University, Shenyang, China.
Jiani LiThe First Clinical Medical School, China Medical University, Shenyang, China.
Ting FanSchool of Intelligent Medicine, China Medical University, Shenyang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Machine learning technology has demonstrated significant potential in glaucoma research, particularly in early diagnosis, predicting disease progression, evaluating treatment responses, and developing personalized treatment strategies. The application of machine learning not only enhances the understanding of the pathological mechanism of glaucoma and optimizes the diagnostic process but also provides patients with accurate medical services. Methods: This study aimed to describe the current state of research, highlight directions for further development, and identify potential trends for improvement. This review was conducted following the scoping review of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) extension to showcase advancements in the application of machine learning in glaucoma research and treatment. Results: We employed a comprehensive search strategy to retrieve literature from the Web of Science Core Collection database, ultimately including 3,581 articles in the analysis. Through data analysis, we identified current research hotspots, noted differences in researchers' attitudes and opinions, and predicted potential future development trends. Discussion: We divided the research topics into six categories, clearly identifying "eye diseases", "retinal fundus imaging" and "risk factors" as the key terms for the development of this field. These findings signify the promising prospects of machine learning, particularly when integrated with multimodal technologies and large language models, to enhance the diagnosis and treatment of glaucoma.

Indexed as

deep learningglaucoma diagnosismachine learningmultimodal imagingophthalmic research

Identifiers

PMID40342583
PMCPMC12059588

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.